期刊文献+

睾丸非精原细胞瘤的治疗(附40例临床分析) 被引量:1

Treatment of Malignant Tumor of the Testis Other than Seminoma
下载PDF
导出
摘要 目的:分析睾丸非精原细胞瘤的疗效。材料与方法:1975年~1990年收治睾丸非精原细胞瘤40例。大部分行患侧高位结扎精索逆行睾丸肿块切除术,部分行腹膜后淋巴结清扫术(RPLND)。29例行术后放疗,并联合化疗。结果:全组5年生存率为45%,Ⅰ、Ⅱ、Ⅲ期分别为73.9%(17/23),10%(l/10)和0%(O/7)(P<0.01)。行RPLND者5年生存率为64.3%(9/14)。结论:据文内资料,病期愈早,疗效愈好;睾丸非精原细胞瘤行RPLND存活率高。主要死亡原因是远处转移。 To analyze the treatment result of non-seminoma malignant tumors of the testis. Methods:A series of 40 patients of malignant tumor of testis other than seminoma were treated from 1975 to 1990.Most of them were firstly treated with orchiectomy and minority were treated with plus lymphadenectomy in abdomen cavity. 29 patients were treated with postoperative radiotherapy and small part of them were combined with irreqular chemotherapy. Results: The overall 5-year survival rates were 45%. The 5-year survival rate for stage Ⅰ patients was 73 .9% (17/23), 10% (l/10)for stage Ⅱ and none(0/7) for stage Ⅲpatients. Patients received lymphadenectomy in abdomen cavity with the five year survival rate of 64. 3%(9/14) which was much better than the other two groups. Conclusion: According to our material, the earlier the stage, the better the survival rate. The patients who received lymphadenectomy in abdomen cavitywas with better results. The chief cause of death was distant metastasis.
机构地区 湖北省肿瘤医院
出处 《河南肿瘤学杂志》 1998年第5期364-365,共2页 Henan Journal of Oncology
关键词 睾丸肿瘤 非精原细胞瘤 治疗 testis, non-semininoma, treatment results
  • 相关文献

参考文献1

  • 1李长青,张明和.睾丸恶性肿瘤的治疗(附94例分析)[J]肿瘤防治研究,1986(01).

同被引文献23

  • 1蒋宇光,陈江华,姜睿,杭格日乐图,王广会,汪东,李福春,刘虎,石长江,吴红军,袁亚光.蒙古族睾丸肿瘤35例临床分析[J].中华男科学杂志,2006,12(5):397-400. 被引量:1
  • 2Albers P,Albrecht W,Algaba F,et al.EAU Guidelines on Testicular Cancer:2011 Update[J] .European Urology,2011:304-329.
  • 3Spermon JR,Hoffmann AL,Horenblas S,et al.European consensus on diagnosis and treatment of germ cell cancer:a report of the European germ cell cancer consensus group (EGCCCG)[J] .Ann Oncol 2004 ; 15:1377-1399.
  • 4Kondagunta GV,Motzer RJ,et al.Adjuvant chemotherapy for stage Ⅱ Nonseminomatous germ-cell tumors[J] .Urol Clin N Am,2007,34:199-185.
  • 5Christian Wintem,David Pfisterb,Jonas Busch,et al.Residual Tumor Size and IGCCCG Risk Classification Predict Additional Vascular Procedures in Patients with Germ Cell Tumors and Residual Tumor Resection:A Multicenter Analysis of the German Testicular Cancer Study Group[J] .European Urology,2012,61:403-409.
  • 6Nicola Nicolai,Rosalba Micelii,Andrea Necchi,et al.Retroperitoneal Lymph Node Dissection with No Adjuvant Chemotherapy in Clinical Stage Ⅰ Nonseminomatous Germ Cell Tumors:Long-Term Outcome and Analysis of Risk Factors of Recurrence[J] .European Urology,2010,58:912-918.
  • 7Stephen D,Beck W,Richard S,et al.Significance of Primary Tumor Size and Preorchiectomy Serum Tumor Marker Level in Predicting Pathologic Stage at Retroperitoneal Lymph Node Dissection in Clinical Stage A Nonseminomatous Germ Cell Tumors[J] .Urology,2007,69 (3):557-779.
  • 8Klein EA.Tumor markers in testis cancer[J] .Urol Clin North Am 1993; 20:67-73.
  • 9Williams SB,McDermott DW,Dock W,et al.Retroperitoneal lymph node dissection in patients with high risk testicular cancer[J] .J Oncol,2009,181(5):2097-2101.
  • 10Cherie H,Dunphy MD,Alberto G,et al.Clinical stage Ⅰ nonseminomatous and mixed germ cell tumors of the testis:A clinic pathologic study of 93 patients on a surveillance protocol after orchiectomy alone[J] .Cancer,1988,62:1203-1206.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部